发明名称 GENOMIC TESTING FOR EFFECTIVE THERAPIES AND DETERMINATION OF DOSING STRATEGY
摘要 Several embodiments disclosed herein relate to methods for calculating a dosing regimen that is tailored specifically to the genetic and metabolic profile of a particular patient. In some embodiments, the dosing regimen is related to administration of the antipsychotic drug clozapine, and the tailoring of the regimen reduces risk of adverse side effects.
申请公布号 WO2015143379(A1) 申请公布日期 2015.09.24
申请号 WO2015US21846 申请日期 2015.03.20
申请人 COMPANION DX REFERENCE LAB, LLC 发明人 ROSENBLATT, KEVIN, P.;GURNANI, PREM, P.;LASECKI, DAVD, W.
分类号 A61P25/18 主分类号 A61P25/18
代理机构 代理人
主权项
地址